Torento, Canada Clinical Trials

A listing of Torento, Canada clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 66 clinical trials
Safety and Efficacy of Eliglustat With or Without Imiglucerase in Pediatric Patients With Gaucher Disease (GD) Type 1 and Type 3

Primary Objective: Evaluate the safety and pharmacokinetics of eliglustat in pediatric patients (2 to <18 years old). Secondary Objective: Evaluate the efficacy of eliglustat and quality of life in pediatric patients (2 to <18 years old).

deficiency
enzyme assay
osteopenia
gaucher disease
cerezyme
Investigational Site Number 1240001
 (0.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +22 other locations
A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

The purpose of this study is to test whether two investigational drugs called CAD106 and CNP520, administered separately, can slow down the onset and progression of clinical symptoms associated with Alzheimer's disease (AD) in participants at the risk to develop clinical symptoms based on their age and genotype.

alzheimer's disease
mental state examination
Accepts healthy volunteers
mini-mental state examination
apolipoprotein e4
The Centre for Memory and Aging
 (4.4 away) Contact site
  • 32 views
  • 20 Sep, 2024
  • +126 other locations
A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin Lymphoma (NHL)

This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/r FL or MZL. The study will be conducted in compliance with the International Council on Harmonisation (ICH) of Technical Requirements for Registration of Pharmaceuticals for Human Use/Good …

b-cell lymphoma
leukapheresis
marginal zone lymphoma
fludarabine
hodgkin's disease
Princess Margaret Cancer Centre
 (0.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +35 other locations
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

The purpose of this study is to demonstrate superiority of macitentan 75 milligrams (mg) in prolonging the time to the first clinical events committee (CEC)-adjudicated morbidity or mortality (M/M) event in participants with symptomatic pulmonary arterial hypertension (PAH) compared to macitentan 10 mg.

connective tissue disease
atrial septal defect
heart disease
ventricular septal defects
HIV Infection
University Health Network - Toronto General Hospital
 (0.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +210 other locations
Blood-Brain-Barrier Disruption With Cerezyme in Patient's With Parkinson's Disease

This clinical trial focus on the delivery of Cerezyme in Parkinson's Disease (PD) patients using MR-guided focused ultrasound (MRgFUS) induced opening of the blood-brain barrier (BBB).

parkinson's disease
Sunnybrook Health Sciences Centre
 (4.7 away) Contact site
  • 16 views
  • 19 Feb, 2024
  • 1 location
Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Chest-wall and Locally-Advanced Breast Cancer

The objective of this study is to demonstrate the feasibility of novel MRI-guided ultrasound stimulated microbubble treatment to enhance radiation effects in humans receiving external beam radiotherapy delivered using a LINAC (linear accelerator) radiation therapy device.

carcinoma
breast cancer staging
potassium
advanced breast cancer
Sunnybrook Health Sciences Centre
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
First in Human Study of M6223 in Participants With Metastatic or Locally Advanced Solid Unresectable Tumors

The main purpose of this study is to determine the safety, tolerability, pharmacokinetics (PK), immunogenicity and (if observed) the maximum tolerated dose (MTD) of M6223 as a single agent (Part 1A) and of M6223 combined with bintrafusp alfa (Part 1B) in participants with metastatic or locally advanced solid unresectable tumors.

Sarah Cannon Research Institute
 (647.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Head and Neck Cancer

The objective of this study is to demonstrate the feasibility of novel MRI-guided ultrasound stimulated microbubble treatment to enhance radiation effects in humans receiving external beam radiotherapy delivered using a LINAC (linear accelerator) radiation therapy device.

neck cancer
external beam radiotherapy
carcinoma
squamous cell carcinoma
head and neck cancer
Gregory J Czarnota
 (4.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Topotecan Episcleral Plaque for Treatment of Retinoblastoma

This single site, single-arm, non-randomized, dose escalation phase I toxicity clinical trial will assess primarily the safety and secondarily the efficacy of episcleral topotecan in patients with active residual or recurrent intraocular retinoblastoma in at least one eye following completion of first-line therapy.

renal function
intraocular retinoblastoma
brachytherapy
topotecan
platelet count
The Hospital for Sick Children
 (0.4 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Benefits of Exercise in Alzheimer's Disease

Exercise has been shown to be beneficial for the brain. The investigators would like to test this specifically for those diagnosed with Alzheimer's disease. This study will involve 30 randomized patients to take part in the out-patient exercise program and 30 patients to continue with their regular activities over a …

cognitive assessment
neuropsychological test
aerobic exercise
dementia
alzheimer's disease
Toronto Western Hospital, WW5-449
 (1.1 away) Contact site
  • 4 views
  • 19 Feb, 2024
  • 1 location